Filing Details

Accession Number:
0001232524-12-000082
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-17 20:31:22
Reporting Period:
2012-08-16
Filing Date:
2012-08-17
Accepted Time:
2012-08-17 20:31:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206977 E Kathryn Falberg C/O Jazz Pharmaceuticals Plc
Connaught House, 1 Burlington Rd, Fl. 4
Dublin 4 L2
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2012-08-16 7,000 $47.48 88,782 No 4 S Direct
Ordinary Shares Disposition 2012-08-16 53,000 $47.57 0 No 4 S Indirect By Kathryn E Falberg Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Kathryn E Falberg Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.29 to $47.78, inclusive.
  2. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) or footnote (4) to this Form 4.
  3. Includes 35,000 restricted stock units granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, August 9, 2012.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.35 to $47.75, inclusive.